• 9430 Key West Avenue Rockville, MD 20850 I (240) 268.1141
  1. Cellphire Investors Again Receive 50% Maryland Biotechnology Investment Incentive Tax Credit

    November 17, 2017

    Cellphire, Inc. announced today that investors who participated in the $3,000,000 Cellphire funding round that closed in June have received their Final Tax Credit Certificates from the Maryland Department of Commerce awarding them a 50% refundable tax credit for their investments in Cellphire.  They are now able to claim the tax refund by filing their […]


  2. BodeVet Chief Technical Officer to Present at IVECCS 2017

    August 1, 2017

    BodeVet Chief Technical Officer, Anne Hale, CVM, will advise on controversies in blood banking at the International Veterinary Emergency and Critical Care Symposium, (IVECCS) 2017 in Nashville, Tennessee.  As a recognized world leader in veterinary blood banking, Dr. Hale joins a select panel of experts for a discussion of veterinary blood banking challenges.  This discussion […]


  3. Cellphire Awarded Grant to Develop Elephant Endotheliotropic Herpesvirus (EEHV) Freeze Platelet Treatment

    July 31, 2017

    Thanks to a grant from the International Elephant Foundation, Cellphire, Smithsonian Global Health Program, Ringling Bros. Center for Elephant Conservation, Fort Worth Zoo and Houston Zoo have made great strides in developing a novel treatment for a lethal virus afflicting baby Asian elephants around the globe.  Elephant Endotheliotropic Herpesvirus (EEHV) is the leading cause of […]


  4. Cellphire Therapeutics Closes $3,000,000 Funding Round

    June 30, 2017

    Cellphire, Inc. announced today that it had closed a $3,000,000 funding round, with investments from both new investors and existing investors, management and the board of directors.  “The additional capital will augment the $69 million commitment from BARDA [the Biomedical Advanced Research and Development Authority],” said CEO Stephen Willard, “and enables us to initiate the […]


  5. Dr. David Hirsh Joins Cellphire Therapeutics, Inc. Board of Directors

    April 30, 2017

    Cellphire, Inc. announced today that David I. Hirsh, Ph.D. has joined the Company’s Board of Directors.  Dr. Hirsh is a Professor in the Department of Biochemistry and Molecular Biophysics at the College of Physicians and Surgeons of Columbia University.  He has served as Chairman of the Department and as Executive Vice President of Research at […]


  6. Dr. Anne Hale, DVM Joins BodeVet as Chief Technical Officer

    April 15, 2017

    Cellphire, Inc. announced that Anne Hale, DVM has joined its veterinary subsidiary BodeVet, Inc. as its Chief Technical Officer.  Dr. Hale is a renowned expert in veterinary transfusion medicine. Dr. Hale has a strong academic track record and has received a NIH Comparative Fellowship in Transfusion Medicine. Dr. Hale founded and guided Midwest Animal Blood […]


  7. BodeVet – StablePlate RX® Launching in September at IVECCS 2017

    March 20, 2017

    This September, the world’s first infusable freeze-dried platelet-derived product will be StablePlate RX® for canines.  StablePlate RX® is a shelf-stable hemostatic agent that couples the healing and hemostatic power of platelets with the stability and convenience of other medicines.  BodeVet will release StablePlate RX® on a limited basis at the International Veterinary and Critical Care […]


  8. Rafael Jorda Joins Cellphire, Inc. as Vice President of R&D

    January 2, 2017

    Cellphire, Inc. announced today that Rafael Jorda has joined the company as Vice President of Research & Development.  Mr. Jorda is an internationally experienced scientific leader with more than 25 years of experience in private and public company management spanning three continents. He has managed the R&D, Intellectual Property, Production, and Business Development operations of […]


  9. In Memory of Dr. Arthur Bode

    November 22, 2016

    The Board, Officers and colleagues at Cellphire, Inc., commemorate their colleague Dr. Arthur P. Bode (b. 1953, d. 2016). Eminent in the field of platelet research, and a joy with whom to work. A gentleman and a scholar, he will be sadly missed.Dr. Arthur (Art) Bode had a background of scientific investigation in platelet function […]


  10. Rodman W. Moorhead, III Joins Cellphire, Inc. Board of Directors

    November 1, 2016

    Rodman W. Moorhead, III Joins Cellphire, Inc. Board of DirectorsNOVEMBER 1, 2016 Rockville, MD, November 1, 2016 – Cellphire, Inc. announced today the appointment of Mr. Rodman W. Moorehead, III to its Board of Directors.  Mr. Moorhead retired from Warburg Pincus, a global private equity firm, after a career spanning 37 years. His last position at […]